• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

6-Oxopiperidine-3-Carboxylic Acid: A Comprehensive Overview

6-Oxopiperidine-3-carboxylic acid, also known by its CAS registry number CAS No. 22540-50-7, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of cyclic ketones and is characterized by its unique structure, which includes a six-membered piperidine ring with a ketone group at position 6 and a carboxylic acid group at position 3. The molecule's structure makes it a versatile building block for various chemical transformations and applications.

The synthesis of 6-Oxopiperidine-3-carboxylic acid has been extensively studied, with researchers exploring efficient methods to produce this compound on both laboratory and industrial scales. Recent advancements in catalytic asymmetric synthesis have enabled the production of enantiomerically pure derivatives, which are highly valuable in drug discovery and development. For instance, studies published in the Journal of Medicinal Chemistry highlight the use of this compound as a key intermediate in the synthesis of bioactive molecules targeting various therapeutic areas, including cancer and neurodegenerative diseases.

In terms of applications, 6-Oxopiperidine-3-carboxylic acid has found utility in diverse fields. In the pharmaceutical industry, it serves as a precursor for peptide-based drugs and other bioactive compounds. Its ability to form stable amide bonds makes it particularly useful in peptide synthesis. Additionally, this compound has been employed in the development of novel materials, such as biodegradable polymers, which are gaining traction in sustainable chemistry research.

Recent research has also focused on the biological properties of 6-Oxopiperidine-3-carboxylic acid. Studies conducted at leading research institutions have demonstrated its potential as an anti-inflammatory agent and its ability to modulate cellular signaling pathways involved in chronic diseases. Furthermore, computational modeling studies have revealed insights into its interactions with key proteins, paving the way for its use in drug design.

The environmental impact of CAS No. 22540-50-7 has also been a topic of interest. Researchers have investigated its biodegradability and toxicity profiles, with findings suggesting that it is relatively non-toxic to aquatic organisms under standard conditions. These studies are crucial for ensuring the safe handling and disposal of this compound in industrial settings.

In conclusion, 6-Oxopiperidine-3-carboxylic acid, or CAS No. 22540-50-7, is a multifaceted compound with applications spanning organic synthesis, pharmacology, and materials science. Its structural versatility and promising biological properties continue to drive innovative research across various disciplines. As advancements in synthetic methods and biological applications unfold, this compound is poised to play an increasingly important role in both academic and industrial settings.

• 276680-34-3(3-Pyrrolidinecarboxylicacid, 4-ethyl-5-oxo-, (3R,4R)-rel-)
• 2060008-69-5(2-oxo-5-propylpiperidine-3-carboxylic acid)
• 2059935-46-3(5-ethyl-2-oxopiperidine-3-carboxylic acid)
• 1537833-71-8(4-methyl-6-oxopiperidine-3-carboxylic acid)
• 2098142-54-0(8-oxo-7-azaspiro[3.5]nonane-5-carboxylic acid)
• 119695-04-4(3-Piperidinecarboxylic acid, 2-oxo-, (±)-)
• 41888-21-5(2-Oxopiperidine-3-carboxylic acid)
• 1517180-89-0(3-Methyl-6-oxopiperidine-3-carboxylic acid)
• 1426408-55-0((3R)-6-oxopiperidine-3-carboxylic acid)
• 1426408-56-1((3S)-6-oxopiperidine-3-carboxylic acid)